The mechanism overlap is the key issue - Reta already activates GLP-1, GIP, and glucagon receptors, so adding tirz mainly adds redundant GIP agonism. The net new contribution is limited to whatever the tirz-specific GIP selectivity adds, which is not well characterized. Most community reports of...